Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Paul A. Schomack, Timothy W. Secomb, Natarajan Raghunand
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Tumor pathophysiology: the perfusion model
10.1159/000386057 · 1980
The Eugene M
1997
Blood flow, oxygen consumption and tissue oxygenation of human tumors
10.1007/978-1-4684-8181-5_103 · 1990
MRI of extracranial masses in children: the usefulness of gadolinium-chelate enhancement
10.1007/s002470050364 · 1998
Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors
10.1006/jmre.1997.1220 · 1997
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
10.1002/jmri.1880070113 · 1997
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement
1997
Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results
10.1002/jmri.1880080406 · 1998
Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI
10.1002/mrm.1910360609 · 1996
Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging
10.1002/jmri.1880070115 · 1997
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging
1991
Water diffusion and exchange as they influence contrast enhancement
10.1002/jmri.1880070114 · 1997
Improving MR quantification of regional blood volume with intravascular Ti contrast agents: accuracy, precision, and water exchange
10.1002/mrm.1910360608 · 1996
Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction
10.1002/mrm.1910340320 · 1995
Analysis of dynamic contrast enhanced MRI in tumors: relationship of derived parameters with physiologic factors
1998
Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy
10.1002/jmri.1880050612 · 1995
Fast dynamic contrast enhanced MR imaging of cervical carcinoma
10.1016/s0009-9260(98)80098-6 · 1998
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging
10.1148/radiology.207.3.9609906 · 1998
Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrastenhanced MR imaging
10.1148/radiology.201.1.8816542 · 1996
Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay
10.1016/s0360-3016(97)85090-0 · 1996
Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging
10.2214/ajr.170.1.9423627 · 1998
Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy
10.1097/00004424-199210000-00016 · 1992
Magnetic resonance imaging in musculoskeletal primary malignant tumors
1987
Blood perfusion measurements in human tumours, evaluation of laser Doppler methods
10.3109/02656739009141139 · 1990
Tumor blood flow
1998
Transplantable tumors grown in transparent chambers in skinflaps of mice
1943
Differential response of normal and tumor microcirculation to hyperthermia
1984
Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber
10.2307/3577110 · 1987
Concepts of oxygen transport at the microcirculatory level
10.1016/s1053-4296(98)80040-4 · 1998
Temporal changes in PO2 of R3230AC tumors in Fischer-344 rats
10.1016/s0360-3016(98)00304-6 · 1998
Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma
1996
The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target
10.1023/a:1006002419244 · 1998
MIBG inhibits respiration: potential for radio- and hyperthermic sensitization
10.1016/s0360-3016(98)00334-4 · 1998
Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation
10.1148/radiology.137.3.7003650 · 1980
Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker
10.1002/(sici)1096-9098(199709)66:1<30::aid-jso7>3.0.co;2-o · 1997
Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry
10.2307/3579280 · 1996
Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water
10.1161/01.str.27.9.1648 · 1996
Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics
10.1016/s0360-3016(98)00306-x · 1998
Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation
10.1002/(sici)1099-1492(199605)9:3<125::aid-nbm405>3.0.co;2-f · 1996
Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation
10.1016/s0360-3016(98)00038-8 · 1998
Physiological properties of malignant tumours
10.1002/nbm.1940050505 · doi-reference
The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging
10.1016/s0360-3016(97)00326-x · doi-reference
Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging
10.1002/mrm.1910390519 · doi-reference
Combined effects of angiostatin and ionizing radiation in antitumour therapy
10.1038/28412 · doi-reference
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents
10.1023/a:1005718628223 · doi-reference
Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma
10.1002/(sici)1520-6823(1998)6:2<71::aid-roi2>3.0.co;2-e · doi-reference
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models
10.1007/s002800050773 · doi-reference
In vivo analysis of tumor vascularization in the rat
10.1111/j.1349-7006.1990.tb02562.x · doi-reference
Microcirculation of Tumors Part 1: anatomy, function and Necrosis
10.1016/s0009-9260(66)80027-2 · doi-reference
Effect of diameter variability along a microvessel segment on pressure drop
10.1006/mvre.1993.1020 · doi-reference
pO2 measurements in arteriolar networks
10.1006/mvre.1996.0021 · doi-reference
Measurements of the perivascular PO2 in the vicinity of the pial vessels of the cat
10.1007/bf00584471 · doi-reference
Arteriolar control of capillary cell flow in striated muscle
10.1161/01.res.64.1.112 · doi-reference
Quantification of longitudinal tissue PO2 gradients in window chamber tumours: impact on tumour hypoxia
10.1038/sj.bjc.6690273 · doi-reference
Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels
10.1007/978-1-4615-4863-8_74 · doi-reference
Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors
10.3109/02841869509093981 · doi-reference
Angiogenesis and cancer metastases: therapeutic approaches
10.1016/1040-8428(94)00142-g · doi-reference
Angiogenesis as a marker of preneoplastic lesions of the human breast
10.1002/1097-0142(197801)41:1<239::aid-cncr2820410133>3.0.co;2-x · doi-reference
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
10.1007/bf00666038 · doi-reference
Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of a multiparametric study
10.1007/bf00666041 · doi-reference
A pial window model for the intracranial study of human glioma microvascular function
10.1227/00006123-199505000-00014 · doi-reference
A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model
10.1016/0360-3016(93)90348-y · doi-reference
Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature
10.1016/0360-3016(89)90375-1 · doi-reference
1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors
10.1007/bf02648108 · doi-reference
Geometric resistance and microvascular network architecture of human colorectal carcinoma
10.3109/10739689709148315 · doi-reference
Resistance to blood flow in microvessels in vivo
10.1161/01.res.75.5.904 · doi-reference
Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
10.1161/01.res.83.8.852 · doi-reference
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
10.1016/s0092-8674(00)81812-7 · doi-reference
Hypoxiamediated induction of acidic/basic fibroblast growth factor and platelet derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
10.1073/pnas.92.10.4606 · doi-reference
Modulation of VEGF production by pH and glucose in retinal Muller cells
10.1076/ceyr.17.9.875.5134 · doi-reference
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
10.1038/28867 · doi-reference
Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
10.1128/mcb.15.10.5363 · doi-reference
Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
10.1172/jci5028 · doi-reference
Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
10.1073/pnas.94.16.8761 · doi-reference
Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate
10.1002/(sici)1097-0215(19971210)73:6<865::aid-ijc17>3.0.co;2-3 · doi-reference
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis
10.1073/pnas.92.3.768 · doi-reference
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
10.1038/359843a0 · doi-reference
Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
10.1002/(sici)1097-0215(19980302)75:5<706::aid-ijc8>3.0.co;2-2 · doi-reference
Oxygen tension regulates the expression of angiogenesis factor by macrophages
10.1126/science.6612342 · doi-reference
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
10.1016/s0092-8674(00)80108-7 · doi-reference